Camblong Jurgi 4

What Happened

• Jurgi Camblong, CEO of SOPHiA GENETICS (SOPH), sold 4,486 shares on May 19, 2026, for total proceeds of $20,658. The reported weighted-average price was $4.60 per share (range $4.54–$4.71). This was a sale (not a purchase) executed to satisfy tax withholding obligations tied to RSU vesting, and thus is a routine, non-discretionary disposition.

Key Details

• Transaction date: 2026-05-19; filing date: 2026-05-20 (appears timely).
• Price: weighted average $4.60; prices ranged from $4.54 to $4.71 across multiple trades.
• Shares sold: 4,486; proceeds: $20,658.
• Shares owned after transaction: not specified in the provided filing details.
• Notable footnotes:
  • The sale was effected pursuant to a pre-established Rule 10b5-1(c) trading plan and was done to meet tax-withholding on RSUs (footnote F1).
  • The reported price is a weighted average covering multiple trades; the filer can provide per-trade price breakdown on request (footnote F2).

Context

• Sales to cover tax withholding after RSU vesting are common and typically administrative rather than indicative of a CEO changing conviction in the company. The use of a Rule 10b5-1 plan indicates the trades were pre-arranged and non-discretionary.